Malaysia targets US$190m medical travel revenue for 2022

The Malaysian government is targeting direct revenue of RM800 million (US$190m) in 2022 and RM1.7 billion (US$400m) in 2025 from the country’s medical tourism sector through initiatives outlined under the recently agreed Malaysian Healthcare Travel Industry Blueprint 2021-2025.

The five -year plan seeks to enhance the healthcare tourism ecosystem, as well as rehabilitate and redevelop the industry.

In 2020 and 2021, Malaysia’s medical tourism sector recorded significant losses due to COVID-19 with the closure of international borders, recording a drop in direct revenue of RM2.2 billion (US$500m).

Efforts made by the Ministry of Health to revive the sector include conducting digital promotion and strategic branding through Malaysia World’s Healthcare Marvel campaign, branding Malaysia as a treatment destination for the ‘Cardiology and Fertility Hub of Asia’ and the ‘Malaysia Cancer Care Centre of Excellence’ programmes.

A digital framework for the medical tourism industry was also drawn up in an effort to enhance and improve the experience of medical tourists while receiving their treatment in the country.